Literature DB >> 19804909

The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations.

John V Williams1, Jörn-Hendrik Weitkamp, David L Blum, Bonnie J LaFleur, James E Crowe.   

Abstract

The human Ab repertoire exhibits restrictions during fetal life characterized by biases of variable gene segment usage and lack of junctional diversity. We tested the hypotheses that Ab repertoire restriction persists in the early postnatal period and contributes to the observed poor quality of specific Ab responses made by neonates to viruses and vaccines. We analyzed the molecular determinants of B cell responses in humans to respiratory syncytial virus (RSV). Analysis of the variable gene segment usage of adult RSV-specific B cells revealed a repertoire profile in these cells similar to that seen in randomly selected B cells, which was V(H)3-dominant. Four gene segments (V(H)3-23, V(H)3-30, V(H)3-33 and V(H)4-04) accounted for almost half of the V(H) genes used. In contrast, very young infant RSV-specific antibodies exhibited a biased repertoire characterized by comparable use of the V(H)1, V(H)3, and V(H)4 families, and less common use of the four immunodominant gene segments. Infants and children older than three months used an antibody repertoire similar to that of adults. Mutational analysis revealed that the antibody variable genes of infants under three months of age also possessed significantly fewer somatic mutations in both framework and complementarity-determining region (CDR) regions than those of adults, even in a child with recurrent RSV infection. These data suggest that neonates use a biased antibody gene repertoire that is less V(H)3-focused and that possesses a dramatically lower frequency of somatic mutations. These biased features of the RSV-specific repertoire likely contribute to the poor functional Ab response in very young infants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804909      PMCID: PMC2788105          DOI: 10.1016/j.molimm.2009.08.024

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  37 in total

1.  IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth.

Authors:  S Shiokawa; F Mortari; J O Lima; C Nuñez; F E Bertrand; P M Kirkham; S Zhu; A P Dasanayake; H W Schroeder
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.

Authors:  A H Brandenburg; J Groen; H A van Steensel-Moll; E C Claas; P H Rothbarth; H J Neijens; A D Osterhaus
Journal:  J Med Virol       Date:  1997-05       Impact factor: 2.327

3.  Frequencies of HIV-reactive B cells in seropositive and seronegative individuals.

Authors:  R H Zubler; L H Perrin; A Doucet; X Zhang; Y P Huang; P A Miescher
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

4.  Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning.

Authors:  A C Lagerkvist; C Furebring; C A Borrebaeck
Journal:  Biotechniques       Date:  1995-05       Impact factor: 1.993

5.  A definitive set of oligonucleotide primers for amplifying human V regions.

Authors:  D Sblattero; A Bradbury
Journal:  Immunotechnology       Date:  1998-01

6.  Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination.

Authors:  S J Corbett; I M Tomlinson; E L Sonnhammer; D Buck; G Winter
Journal:  J Mol Biol       Date:  1997-07-25       Impact factor: 5.469

7.  Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction.

Authors:  H P Brezinschek; R I Brezinschek; P E Lipsky
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

Review 8.  Developmental regulation of the human antibody repertoire.

Authors:  H W Schroeder; F Mortari; S Shiokawa; P M Kirkham; R A Elgavish; F E Bertrand
Journal:  Ann N Y Acad Sci       Date:  1995-09-29       Impact factor: 5.691

9.  Human cord blood antibody repertoire. Mixed population of VH gene segments and CDR3 distribution in the expressed C alpha and C gamma repertoires.

Authors:  F Mortari; J Y Wang; H W Schroeder
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  20 in total

1.  Influenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem.

Authors:  Elene Clemens; Davide Angeletti; Beth C Holbrook; Masaru Kanekiyo; Matthew J Jorgensen; Barney S Graham; Jonathan Yewdell; Martha A Alexander-Miller
Journal:  JCI Insight       Date:  2020-03-12

2.  Development of newborn and infant vaccines.

Authors:  Guzman Sanchez-Schmitz; Ofer Levy
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

Review 3.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

4.  Expressed antibody repertoires in human cord blood cells: 454 sequencing and IMGT/HighV-QUEST analysis of germline gene usage, junctional diversity, and somatic mutations.

Authors:  Ponraj Prabakaran; Weizao Chen; Maria G Singarayan; Claudia C Stewart; Emily Streaker; Yang Feng; Dimiter S Dimitrov
Journal:  Immunogenetics       Date:  2011-12-27       Impact factor: 2.846

Review 5.  Immune responses to congenital cytomegalovirus infection.

Authors:  Ilija Brizić; Lea Hiršl; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

Review 6.  Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Authors:  Peter L Collins; José A Melero
Journal:  Virus Res       Date:  2011-09-22       Impact factor: 3.303

Review 7.  Progress in respiratory virus vaccine development.

Authors:  Alexander C Schmidt
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 8.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

9.  Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.

Authors:  Eileen Goodwin; Morgan S A Gilman; Daniel Wrapp; Man Chen; Joan O Ngwuta; Syed M Moin; Patricia Bai; Arvind Sivasubramanian; Ruth I Connor; Peter F Wright; Barney S Graham; Jason S McLellan; Laura M Walker
Journal:  Immunity       Date:  2018-02-03       Impact factor: 31.745

10.  Developmental progression of equine immunoglobulin heavy chain variable region diversity.

Authors:  Rebecca L Tallmadge; Chia T Tseng; Rebecca A King; M Julia B Felippe
Journal:  Dev Comp Immunol       Date:  2013-04-06       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.